Clin2
NCT07475936Possibly a fitRecruiting

Tenecteplase for very old patients with stroke

Acute Ischemic StrokeTenecteplase

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests if a clot-busting drug called tenecteplase is safe and effective for people over 80 who have an ischemic stroke and can get treatment within 4.5 hours of symptoms starting.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
392 people
Ages
80 years and older
Study type
Observational

Who can take part

  • You must be over 80 years old.
  • You must have an ischemic stroke and arrive at the hospital within 4.5 hours of symptoms starting.
  • You or a family member must sign a form agreeing to participate.
  • You cannot have any medical reason that would make thrombolysis dangerous (other than your age).
  • You cannot have already received another clot-busting drug for this stroke.
  • You cannot be in another research study right now.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07361302Recruiting· Phase 3
Tenecteplase for stroke after 4.5 hours

This trial tests a clot-dissolving medicine called tenecteplase for people who had a stroke more than 4.5 hours ago. It may help you recover if given later than usual.

Buenos Aires
NCT07606807Recruiting· Phase 3
New clot-busting medication for stroke in the extended time window

This trial tests a new medication called rhTNK-tPA for treating acute ischemic stroke (a clot in the brain) up to 24 hours after symptom onset. The study uses simplified imaging to determine eligibility and aims to help patients recover better outcomes.

Guangzhou
NCT07092709Recruiting· Phase 3
Tenecteplase for stroke patients who recently took blood thinners

This trial tests if the clot-busting drug tenecteplase is safe and effective for people having an ischemic stroke who have recently taken blood thinners (DOACs). If you qualify, you may receive either tenecteplase or a placebo within 24 hours of your last known well time.

Guangzhou, Guangdong
NCT07168278Not yet recruiting· Phase 3
Clot-busting drug vs standard care for late large-vessel stroke

This trial tests whether a clot-dissolving drug called tenecteplase can improve recovery for people who had a large-vessel ischemic stroke 4.5 to 24 hours earlier and can’t have a mechanical clot removal procedure in time. If you join, you’ll get either tenecteplase or standard medical care, and the study will track your recovery and safety.

Hefei, Anhui
NCT07475949Recruiting· Phase 3
Stroke treatment for unknown wake-up time

This trial tests a clot-busting drug for people who had a stroke but don't know when it started, like waking up with symptoms. It may help reduce disability if given soon after noticing symptoms.

Xiamen, Fujian
NCT07094763Recruiting
Tenecteplase for posterior stroke 4.5-24 hours after onset

This trial tests a clot-busting drug called tenecteplase for people who had a stroke affecting the back part of the brain (posterior circulation). It may be an option if you can get treatment between 4.5 and 24 hours after symptoms started.

Hefei

Hear when a new Acute Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.